|
|
|
|
|
|
Human
|
|
|
|
|
|
|
Angiotensinogen antibody
- DataSheet
- Bio-information
- Related Products
|
|
|
|
|
|
| Catalog Number | GTX111199 |
|---|
| Product Name | Angiotensinogen antibody |
|---|
| Full Name | angiotensinogen (serpin peptidase inhibitor, clade A, member 8) |
|---|
| Synonyms | AGT|ANHU|FLJ92595|FLJ97926|SERPINA8|angiotensinogen (serpin peptidase inhibitor, clade A, member 8) |
|---|
| Product Description | Rabbit Polyclonal Angiotensinogen antibody ( angiotensinogen (serpin peptidase inhibitor, clade A, member 8)) |
|---|
| Background | The protein encoded by this gene, pre-angiotensinogen or angiotensinogen precursor, is expressed in the liver and is cleaved by the enzyme renin in response to lowered blood pressure. The resulting product, angiotensin I, is then cleaved by angiotensin converting enzyme (ACE) to generate the physiologically active enzyme angiotensin II. The protein is involved in maintaining blood pressure and in the pathogenesis of essential hypertension and preeclampsia. Mutations in this gene are associated with susceptibility to essential hypertension, and can cause renal tubular dysgenesis, a severe disorder of renal tubular development. Defects in this gene have also been associated with non-familial structural atrial fibrillation, and inflammatory bowel disease. [provided by RefSeq] |
|---|
| Host | Rabbit |
|---|
| Clonality | Polyclonal |
|---|
| Immunogen | Recombinant protein fragment contain a sequence corresponding to a region within amino acids 78 and 248 of Angiotensinogen |
|---|
| Antigen Species | Human |
|---|
| Species Cross Reactivity | human - Not yet tested in other species |
|---|
| Tested Applications | Immunohistochemistry, Western blot. The usefulness of this product in other applications has not been determined. |
|---|
| Application Note | Suggested starting dilutions are as follows. WB: 1:500-1:3000,IHC-P: 1:100-1:500. Not yet tested in other applications. Optimal working dilutions should be determined experimentally by the end user. |
|---|
| Positive Controls | Raji |
|---|
| Predicted Target Size(KDa) | 53 |
|---|
| Cellular Localization | 0 |
|---|
| Form Supplied | Liquid |
|---|
| Concentration | 1 mg/ml |
|---|
| Purification | Purified by antigen-affinity chromatography. |
|---|
| Storage Buffer | 0.1M Tris, 0.1M Glycine, 10% Glycerol (pH7). 0.01% Thimerosal was added as a preservative. |
|---|
| Storage Instruction | Keep as concentrated solution. Aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles. |
|---|
| Notes | For In vitro laboratory use only. Not for any clinical, therapeutic, or diagnostic use in humans or animals. Not for animal or human consumption. |
|---|
|
|
|
|
|
|
|